14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.55 $18.63 Wednesday, 24th Apr 2024 ACAD stock ended at $16.59. This is 0.90% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.72% from a day low at $16.55 to a day high of $16.84.
90 days $16.55 $27.94
52 weeks $16.55 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jul 10, 2023 $24.27 $24.77 $24.03 $24.77 1 177 427
Jul 07, 2023 $24.32 $24.92 $24.32 $24.40 1 233 603
Jul 06, 2023 $24.04 $24.32 $23.98 $24.23 829 382
Jul 05, 2023 $23.97 $24.31 $23.67 $24.16 1 023 932
Jul 03, 2023 $23.84 $24.15 $23.68 $24.00 430 041
Jun 30, 2023 $24.16 $24.24 $23.91 $23.95 621 144
Jun 29, 2023 $24.16 $24.85 $23.97 $24.00 950 953
Jun 28, 2023 $24.35 $24.55 $24.00 $24.17 899 735
Jun 27, 2023 $23.94 $24.40 $23.84 $24.22 1 118 530
Jun 26, 2023 $24.45 $24.65 $23.81 $23.86 897 645
Jun 23, 2023 $23.80 $24.57 $23.77 $24.51 1 590 901
Jun 22, 2023 $23.96 $24.46 $23.80 $24.04 691 449
Jun 21, 2023 $23.83 $24.12 $23.36 $24.09 643 443
Jun 20, 2023 $23.86 $24.03 $23.52 $23.84 746 669
Jun 16, 2023 $24.69 $24.69 $23.98 $24.07 1 173 292
Jun 15, 2023 $24.15 $24.58 $24.07 $24.39 1 063 004
Jun 14, 2023 $25.20 $25.20 $24.07 $24.14 1 834 293
Jun 13, 2023 $24.64 $25.09 $24.64 $25.03 981 527
Jun 12, 2023 $24.88 $25.04 $24.37 $24.61 1 357 553
Jun 09, 2023 $25.02 $25.22 $24.64 $24.72 662 161
Jun 08, 2023 $24.36 $25.55 $24.45 $25.09 1 113 053
Jun 07, 2023 $24.08 $24.80 $23.76 $24.63 944 460
Jun 06, 2023 $24.02 $24.23 $23.87 $23.99 735 585
Jun 05, 2023 $24.36 $24.36 $23.91 $23.97 843 684
Jun 02, 2023 $24.10 $24.61 $24.03 $24.61 1 088 417
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT